Effectiveness of a Novel Low-level Laser Therapy Protocol in Managing Breast Cancer-Related Lymphedema

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 26, 2024

Study Completion Date

December 31, 2024

Conditions
Breast Cancer
Interventions
DEVICE

Low-Level Laser Therapy (904 nm)

Low-level laser therapy using the LTU-904 device (RianCorp, Australia) at a wavelength of 904 nm, applied to the fibrotic area of the upper limb after CDPT.

DEVICE

Low-Level Laser Therapy (650 nm)

Low-level laser therapy using the Salus Talent device (Remed, USA) at a wavelength of 650 nm, applied to the fibrotic area of the upper limb after CDPT.

DEVICE

Sham Laser Therapy

Placebo laser therapy with no active laser emission, administered after CDPT.

Trial Locations (1)

49241

Pusan National University Hospital, Busan

All Listed Sponsors
lead

Pusan National University Hospital

OTHER

NCT07072780 - Effectiveness of a Novel Low-level Laser Therapy Protocol in Managing Breast Cancer-Related Lymphedema | Biotech Hunter | Biotech Hunter